Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 20: 834-837, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uete, T.
Right arrow Articles by Shimizu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uete, T.
Right arrow Articles by Shimizu, S.

Clinical Chemistry, Vol 20, 834-837, Copyright © 1974 by the American Association for Clinical Chemistry

Refinement and Critical Evaluation of a Fluorometric Method for Measuring Leucine Aminopeptidase Activity in Serum or Tissues

Tetsuo Uete 1, Noriko Shimano 1, and Shuko Shimizu 1

1 Kitano Hospital, Tazuke Kofukai Medical Research Institute, kita-ku, Osaka City, Japan.

The fluorometric method for measuring leucine aminopeptidase (EC 3.4.11.1) activity in biological systems, with L-leucyl-beta-naphthylamide as the substrate [Clin. Chem. 16, 412 (1970)] was critically evaluated and refined. In this enzyme assay system, a few precautions are necessary in determining beta-naphthylamine liberated from the substrate by the enzyme action. In water, tris(hydroxymethyl) aminomethane buffer, and ethanol, beta-naphthylamine, excited at 280 nm, fluoresces at 400 nm with a greater intensity than when an excitation wavelength of 340 nm is used. However, in the presence of protein or substrate the fluorescence intensity with an excitation wavelength of 280 nm is markedly diminished, and is less intense than that with 340 nm. Therefore, an excitation wavelength of 340 nm is preferred to 280 nm, to obtain increased sensitivity. Bilirubin and hemoglobin also slightly diminish the fluorescence intensity.

Submitted on July 23, 1973
Accepted on May 2, 1974







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.